Open calls for funding

ITEA is an industry-driven European ecosystem for collaborative R&D projects on software-intensive systems. ITEA projects cover all topics related to software innovation, including:

• Artificial intelligence (e.g. large language models and other generative AI)
• Smart healthcare
• Cybersecurity (digital safety and security)
• Industry 4.0 and smart engineering, including simulation tools, digital twins, robotics and IoT
• Sustainability, including smart mobility and smart cities

Participating countries include Austria, Belgium (Flanders: VLAIO; Brussels: Innoviris; Wallonia: SPW), Canada, the Czech Republic, Germany, Denmark, Spain, Estonia, Finland, France, the United Kingdom, Hungary, South Korea, Lithuania, the Netherlands, Portugal, Romania, Sweden and Turkey.

Deadline: 10 November 2025 (concept); 29 May 2026 (full proposal)

More information

The call will officially open in December 2025. Detailed information on eligibility, guidelines, and application procedures will be published on the dedicated call website in the coming months. A webinar and Q&A session will also be organised to support prospective applicants.

Adolescence is a crucial period of self-discovery and discovery of others, but this very specific and enriching stage has its own particular challenges: Teenagers question their own existence and often seek to develop their strengths and abilities, realise their potential and live life to the full, which drives them to nurture and grow what is alive within them.

They renew their sense of existence and identity by exploring, accepting and embracing their rapidly changing bodies. Body-based practices help them to become aware of what is happening inside them, to adapt and to integrate into reality while maintaining a personal representation of what is fundamental to them.

With this call for proposals, the Huoshen Fund aims to support organisations developing psychophysical activities for adolescents in order to raise their awareness of the importance of taking care of their lives by learning a body-based practice under the guidance of qualified trainers.

Budget: 5.000 euro
Deadline: 06 January 2026

More information

Focus on mechanisms of their onset and progression, neglected determinants and novel strategies for critical transitional periods in life. Applications must cover only one of the two following topics:

1. Research that improves the understanding of the causes for obesity, overweight and its complications by using a mechanistic approach.
2. Research that focuses on prevention and public health strategies for critical transitional periods of life.

Deadline: 21 January 2026 (pre-proposal), 11 June 2026 (full proposal)

More information

The European Partnership for Personalised Medicine, EP PerMed supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).

EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.

The call will be implemented in two stages, i.e. a pre- and a full proposal phase.

Belgium (FIO VLAIO)

Additional documents to be sent via the regional submission platform (E-Tool). Documents required for submission at VLAIO available at: https://www.vlaio.be/nl/media/1488 (ENG) or https://www.vlaio.be/nl/media/1490 (NL)

Belgium (SPW-EER)
Additional documents to be sent via the regional submission platform.

Deadline: 12 January 2026 (pre-proposal); 27 April 2026 (full-proposal)

Together with the partnership ‘Fostering a European Research Area for Health Research’ (ERA4Health), KCE Trials is happy to announce the “Trials4Health 2026” call will open on 6 November 2025.

This call provides funding for multi-country, comparative effectiveness or drug repurposing Investigator-Initiated Clinical Studies (IICS) in Cardiovascular, Autoimmune and Metabolic diseases. Deadline for submission will be 27 January 2026.

More information

Deadline: 31 January 2026

More information

The aim of this first EUP OHAMR Call, foreseen to be launched on 18 November, is to improve the treatment success rates of the patients, animals and plants affected by bacterial or fungal infections by providing new treatment options while reducing the risk of resistance in the different One Health settings. 

Proposals submitted under the call need to address one of the following topics:

• Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance
• Topic 2: Develop tools and methods to improve adherence to treatment protocols
• Topic 3: Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use

Deadline: 2 February 2026 (pre-proposal)

More information

Financial contribution to joint research into genetic diseases between a research team from Belgium and a team from the Institut Imagine France.

Budget: 200.000 euro
Deadline: 03 February 2026

More information

Deadline: 10 February 2026 (pre-proposal), 9 June 2026 (full proposal)

More information